Today in News History

On July 12, several notable moments in the history of News stand out. In 472, Anthemius, Roman emperor (born 420) passed away. In 1797, Ienăchiță Văcărescu, Romanian historian and philologist (born 1740) passed away. In 1943, Richard Carleton, Australian journalist (died 2006) was born. In 1944, Patricia Polacco, American author and illustrator was born. In 1953, Ivan Toms, South African physician and activist (died 2008) was born. In 1987, Avi Ran, Israeli footballer (born 1963) passed away. In 1990, Mona Barthel, German tennis player was born. In 1995, Yugoslav Wars: Srebrenica massacre begins; lasts until 22 July. In 2014, Bill McGill, American basketball player (born 1939) passed away. In 2021, Richard Branson becomes the first civilian to be launched into space via his Virgin Galactic spacecraft. Together, these milestones provide historical context for today's news news and ongoing narratives.

Matica Bio, VaxDome partner on antiviral hybrid vaccine development

The korea Herald News

The korea Herald News

·

July 7, 2026

·

center
Matica Bio, VaxDome partner on antiviral hybrid vaccine development

Matica Biotechnology, the US contract development and manufacturing organization subsidiary of CHA Biotech, has partnered with Texas-based VaxDome Inc. to jointly develop an antigen-agnostic antiviral vaccine aimed at protecting against a broad range of infectious diseases. The collaboration will focus on advancing VaxDome's hybrid antiviral vaccine candidates into clinical trials. Under the agreement, Matica Biotechnology will provide process development, analytical development and the producti

Narrative Intelligence Brief

This article was published by The korea Herald News, a source frequently categorized with a center bias based in South Korea. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of The korea Herald News, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

6 sources

Left 50%

Center 0%

Right 50%


TASS

right

· Jun 24, 2026

Preclinical studies of dengue vaccine have demonstrated its safety — official

Veronika Skvortsova said the vaccine is designed to protect against all four dengue virus serotypes

Bloomberg

lean left

· Jun 25, 2026

Moderna CEO: Cautiously Optimistic on Flu Vaccine Approval

The FDA advisory committee recommended Moderna's flu vaccine for approval. Moderna CEO Stéphane Bancel tells Romaine Bostick and Katie Greifeld he is cautiously optimistic the approval will happen. (Source: Bloomberg)

Seeking Alpha

lean right

· Jun 24, 2026

Moderna: Flu Vaccine Progress Is Only Part Of The Story

Moderna: Flu Vaccine Progress Is Only Part Of The Story

Hindustan Times

lean left

· Jul 8, 2026

Train the cell, then deploy: Science behind the new HIV study, and why it's a foothold, not a finish line

After decades of failed HIV vaccines, a new approach that predicts which cells to train, not just what antigen to show, has produced antibodies.

CBC News

lean left

· Jul 1, 2026

mRNA vaccines proved safe and effective during COVID, review says. Cancer could be next

The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including cancer, according to a new review published in The Lancet Tuesday.

SundayTimes

lean right

· Jul 9, 2026

SA pharma firm Xylomed develops potential Ebola drug

A South African pharmaceutical company has developed a candidate treatment for the Ebola virus and is preparing to begin a clinical trial in parts of Africa affected by recurring outbreaks.

Topics:

World · 3
Business · 2
Politics · 1

Related coverage for "Matica Bio, VaxDome partner on antiviral hybrid vaccine development": TASS — Preclinical studies of dengue vaccine have demonstrated its safety — official. Bloomberg — Moderna CEO: Cautiously Optimistic on Flu Vaccine Approval. Seeking Alpha — Moderna: Flu Vaccine Progress Is Only Part Of The Story. Hindustan Times — Train the cell, then deploy: Science behind the new HIV study, and why it's a foothold, not a finish line. CBC News — mRNA vaccines proved safe and effective during COVID, review says. Cancer could be next. SundayTimes — SA pharma firm Xylomed develops potential Ebola drug